Compounds > nps-568
Page last updated: 2024-09-04

nps-568 and Calcinosis

nps-568 has been researched along with Calcinosis in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (88.89)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bala, G; Caveliers, V; Cosyns, B; Delvenne, E; Delvenne, P; Droogmans, S; Hostens, J; Lahoutte, T; Roosens, B; Schiettecatte, J; Somja, J; Van Camp, G1
Alam, MU; Alexander, MY; Canfield, AE; Kirton, JP; Martin, D; Riccardi, D; Rouhi, M; Sage, AP; Sinha, S; Towers, E; Vizard, TN; Ward, DT; Wilkinson, FL1
Al-Aly, Z1
Gross, ML; Koleganova, N; Piecha, G; Ritz, E; Schmitt, CP1
Caudrillier, A; Drüeke, TB; Fukagawa, M; Hamada, Y; Ivanovski, O; Joki, N; Kamel, S; Lacour, B; Maizel, J; Massy, ZA; Mentaverri, R; Nguyen-Khoa, T; Nikolov, IG; Phan, O1
Chen, NX; Chen, X; Duan, D; Gattone, VH; Henley, C; Martin, D; Moe, SM; Seifert, MF; Sinders, RM1
Cunningham, J1
Aguilera-Tejero, E; Almaden, Y; Lopez, I; Martin, D; Mendoza, FJ; Perez, J; Rodriguez, M1
Boedigheimer, M; Damore, M; Fitzpatrick, D; Haas, K; Henley, C; Kiaei, P; Lacey, DL; Manoukian, R; Martin, D; McNinch, J; Shalhoub, V; Shatzen, E; Twomey, B; Ward, S1

Reviews

2 review(s) available for nps-568 and Calcinosis

ArticleYear
The new role of calcimimetics as vasculotropic agents.
    Kidney international, 2009, Volume: 75, Issue:1

    Topics: Aniline Compounds; Calcinosis; Calcium; Cardiovascular Diseases; Cinacalcet; Humans; Naphthalenes; Phenethylamines; Propylamines; Receptors, Calcium-Sensing

2009
[Management of secondary hyperparathyroidism].
    Clinical calcium, 2005, Volume: 15 Suppl 1

    Topics: Aniline Compounds; Calcinosis; Calcium; Cinacalcet; Clinical Trials as Topic; Drug Design; Drug Therapy, Combination; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Phenethylamines; Phosphorus; Polyamines; Practice Guidelines as Topic; Propylamines; Receptors, Calcium-Sensing; Sevelamer; Vascular Diseases; Vitamin D

2005

Other Studies

7 other study(ies) available for nps-568 and Calcinosis

ArticleYear
Echocardiographic integrated backscatter for assessing reduction of aortic valve calcifications by R-568 in a rat model of chronic kidney disease.
    Ultrasound in medicine & biology, 2013, Volume: 39, Issue:11

    Topics: Aniline Compounds; Animals; Aortic Valve; Bicuspid Aortic Valve Disease; Calcinosis; Echocardiography; Heart Defects, Congenital; Heart Valve Diseases; Image Interpretation, Computer-Assisted; Male; Phenethylamines; Propylamines; Rats; Rats, Wistar; Renal Insufficiency, Chronic; Reproducibility of Results; Scattering, Radiation; Sensitivity and Specificity; Systems Integration; Treatment Outcome

2013
Calcification is associated with loss of functional calcium-sensing receptor in vascular smooth muscle cells.
    Cardiovascular research, 2009, Feb-01, Volume: 81, Issue:2

    Topics: Aniline Compounds; Animals; Calcinosis; Calcium; Cattle; Cells, Cultured; Chronic Disease; Extracellular Signal-Regulated MAP Kinases; Gadolinium; Humans; Kidney Diseases; Minerals; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phenethylamines; Phosphorylation; Propylamines; Receptors, Calcium-Sensing

2009
A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia.
    Kidney international, 2009, Volume: 75, Issue:1

    Topics: Aniline Compounds; Animals; Aorta; Calcinosis; Calcitriol; Calcium; Cell Proliferation; Endothelium, Vascular; Gene Expression Regulation; Muscle, Smooth, Vascular; Phenethylamines; Propylamines; Rats; Rats, Sprague-Dawley; Receptors, Calcitriol; Receptors, Calcium-Sensing; Renal Insufficiency; Uremia

2009
The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE-/-) mice.
    Atherosclerosis, 2009, Volume: 205, Issue:1

    Topics: Aniline Compounds; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Calcinosis; Calcium; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Kidney Failure, Chronic; Mice; Mice, Transgenic; Phenethylamines; Phosphorus; Propylamines; Receptors, Calcium-Sensing; Uremia

2009
R-568 reduces ectopic calcification in a rat model of chronic kidney disease-mineral bone disorder (CKD-MBD).
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2009, Volume: 24, Issue:8

    Topics: Aniline Compounds; Animals; Calcinosis; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Disease Models, Animal; Hyperparathyroidism; Male; Minerals; Phenethylamines; Polycystic Kidney, Autosomal Dominant; Propylamines; Rats; Rats, Sprague-Dawley

2009
Calcimimetic R-568 decreases extraosseous calcifications in uremic rats treated with calcitriol.
    Journal of the American Society of Nephrology : JASN, 2006, Volume: 17, Issue:3

    Topics: Aniline Compounds; Animals; Biopsy, Needle; Blood Chemical Analysis; Calcinosis; Calcitriol; Disease Models, Animal; Drug Therapy, Combination; Immunohistochemistry; Male; Nephrectomy; Phenethylamines; Probability; Propylamines; Rats; Rats, Wistar; RNA, Messenger; Sensitivity and Specificity; Survival Rate; Uremia

2006
Calcification inhibitors and Wnt signaling proteins are implicated in bovine artery smooth muscle cell calcification in the presence of phosphate and vitamin D sterols.
    Calcified tissue international, 2006, Volume: 79, Issue:6

    Topics: Alkaline Phosphatase; Aniline Compounds; Animals; Aorta; Calcinosis; Calcitriol; Calcium; Cattle; Cells, Cultured; Drug Combinations; Ergocalciferols; Gene Expression; Glycerophosphates; Muscle, Smooth, Vascular; Oligonucleotide Array Sequence Analysis; Phenethylamines; Phosphorus; Propylamines; Receptors, Calcitriol; Receptors, Calcium-Sensing; Signal Transduction; Wnt Proteins

2006